Medical - Healthcare Plans · NYSE
Current Price
$200.29
PE Ratio (TTM)
1251.8x
Intrinsic Value
Use the calculator below to estimate
COMPETITIVE MOAT
↑Government Contract Expertise
Molina excels in navigating complex government contracts for Medicaid and Medicare. This deep understanding creates high switching costs for government entities.
↑Scale in Government Programs
Significant scale in serving government-sponsored health plans provides operational efficiencies and a strong negotiating position with providers.
↑Member Engagement in Underserved Areas
Molina's focus on low-income and vulnerable populations fosters strong member relationships and trust, leading to retention.
INVESTMENT RISKS
↓Membership Volatility
Declining membership, as seen in Q2 2026, directly impacts premium revenues and profitability. This can be driven by economic factors or competitor actions.
↓Operational Efficiency Challenges
While Q2 2026 saw lower operating expenses, maintaining efficiency across diverse government programs is a constant challenge. Unexpected cost increases can hurt margins.
↓Investment Income Fluctuations
Softer investment income, as reported in Q2 2026, highlights sensitivity to market conditions. This can create earnings volatility.
Adjust the target PE, earnings growth, and discount rate to see how the fair value and margin of safety for Molina Healthcare, Inc. respond.
Open PE Calculator for MOHMolina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare programs, in addition to state health insurance marketplaces. Its operations are strategically segmented into four main divisions: Medicaid, Medicare, Marketplace, and a general "Other" category. By the close of 2021, specifically December 31st, Molina Healthcare's network extended to approximately 5.2 million members across 18 states, all of whom qualified for Medicaid, Medicare, or other government-sponsored healthcare plans. Established in 1980, the company maintains its corporate headquarters in Long Beach, California.
PE Ratio (TTM)
1251.8x
PEG Ratio
n/m
Earnings Yield
-0.07%
ROE (TTM)
-0.2%
Revenue/Share (TTM)
$867.88
Debt/Equity
0.95x
The trailing twelve-month PE ratio of MOH reflects how much investors pay per dollar of Molina Healthcare, Inc.'s earnings. This metric is most useful when compared to Medical - Healthcare Plans peers and the company's own historical range.
MOH's PE of 1251.8x combined with a PEG ratio of -12.62 provides a growth-adjusted perspective. MOH has negative earnings, so its PE and PEG ratios are not meaningful here and cannot tell you whether the stock is over or undervalued. Keep in mind that PE-based valuation works best for profitable, mature companies — for high-growth or cyclical Medical - Healthcare Plans, a DCF analysis may be more appropriate.
To value Molina Healthcare, Inc. using PE: (1) Compare the current PE (1251.8x) against the Medical - Healthcare Plans median to assess relative pricing, (2) check the PEG ratio (-12.62) to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.
MOH's PEG ratio is -12.62, calculated by dividing the PE ratio (1251.8x) by the expected earnings growth rate. Because MOH has negative earnings, its PEG ratio is not meaningful and should not be read as a sign of under or overvaluation. Note that PEG accuracy depends on the reliability of growth estimates.
PE ratio gives a quick relative read — how MOH is priced versus Medical - Healthcare Plans peers. DCF provides an absolute value based on projected free cash flows. For the most reliable valuation, use PE as a quick comparability screen and DCF for a deeper fundamental analysis. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.
P/E and DCF value MOH with different methods and assumptions, so the two conclusions can differ. Compare the DCF intrinsic value.
Price as of 2026-08-21. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.
This is an estimate, not investment advice.